- The Icahn School of Medicine at Mount Sinai is part of the Mount Sinai Health System.
- Miriam Merad leads the NYC-Vita clinical trial team as the Icahn School of Medicine at Mount Sinai integrates clinical trials and research enterprise.
Field Medical Publishes 12-Month Results of PFA Clinical Trial
2 reports, 1 independent
Updated Sep 20
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Field Medical, Inc. announced the publication of 12-month results from the Field PULSE trial in JACC: Clinical Electrophysiology. The study evaluated the FieldForce™ PFA System for high-voltage focal pulsed field ablation (PFA) in the atrium. Key findings included a median elapsed PVI ablation time of 13 minutes and 94.2% per-vein durability using the optimized waveform.
Why it matters
The results advance the use of instantaneous ablation workflows for complex arrhythmias. The findings demonstrate procedural efficiency and durable pulmonary vein isolation, which could influence clinical adoption of the PFA technology.
Who's involved
- Mount Sinai Health SystemHealthcare provider network where the study's findings may be applied
- Mount Sinai HospitalHospital in Manhattan, New York City, United States
Keep exploring
The entities involved
-
Mount Sinai Health System
US hospital network
Nothing else this week.
-
Vivek Reddy
researcher (ORCID 0000-0001-9165-7232)
Nothing else this week.